Committed to Ophthalmic Practices
RXQ Compounding produces several sterile medications specific to the ophthalmology clinical and surgical suite setting needs. These are produced in our new, 42,500 square foot, State-of-the-art compounding facility, within ISO-5 level hoods under cGMP standards. All batches of RXQ produced sterile products are end-product tested, which includes drug assay, endotoxin content, particulate matter, and sterility. All products are held in quarantine until these test results are received.
Popular Ophthalmology Products